![Anthony Manning](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Anthony Manning
Director/Board Member at
MONTE ROSA THERAPEUTICS, INC.
Net worth: 14 571 $ as of 2026-04-29
Profile
Currently, Anthony M. Manning is Chairman of Institute For Biomedical Entrepreneurship, Inc. and Chief Scientific Officer of Momenta Pharmaceuticals, Inc. Dr. Manning is also on the board of Palatin Technologies, Inc. Dr. Manning previously held the position of SVP-Research & Preclinical Development at Aileron Therapeutics, Inc., Vice President & Head-Autoimmune Diseases Research at Biogen, Inc., Head-Research at Celgene Corp., Vice President & Global Head-Inflammation at Roche Pharmaceuticals, Inc., Principal at Signal Pharmaceuticals, Inc. and Vice President at Pharmacia Corp. He received a doctorate from the University of Otago.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2025-06-19 | 721 ( 0.04% ) | 14 571 $ | 2026-04-29 | |
| 2025-06-12 | 0 ( -.--% ) | - $ | 2026-04-29 |
Anthony Manning active positions
| Companies | Position | Start |
|---|---|---|
| MONTE ROSA THERAPEUTICS, INC. | Director/Board Member | 2023-07-24 |
Institute For Biomedical Entrepreneurship, Inc. | Founder | - |
Former positions of Anthony Manning
| Companies | Position | End |
|---|---|---|
| REIN THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 2012-12-31 |
| BIOGEN INC. | Corporate Officer/Principal | 2011-03-31 |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Corporate Officer/Principal | 2007-07-31 |
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Corporate Officer/Principal | 2001-12-31 |
| MOMENTA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Anthony Manning
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
88
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Palatin Technologies, Inc.
 Palatin Technologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops medicines based on molecules for the modulation of melanocortin receptor system | Health Technology |
Signal Pharmaceuticals, Inc.
 Signal Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biopharmaceutical research focused on the discover of new drugs | Commercial Services |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Commercial Services |
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that discovers and develops novel biologic therapies for the treatment of rare immune-mediated diseases | Health Technology |
Rein Therapeutics, Inc.
 Rein Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops stapled peptide drugs | Health Technology |
University of Otago
 University of Otago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Health Technology |
Institute For Biomedical Entrepreneurship, Inc. | |
Monte Rosa Therapeutics, Inc.
 Monte Rosa Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops molecular glue degrader medicines for oncology, autoimmune and inflammatory diseases | Health Technology |
- Stock Market
- Insiders
- Anthony Manning
